ALNY vs AMR · P/E 76, rev $1.29B vs P/E 58, rev $1.02B
Alnylam Pharmaceuticals Inc (ALNY) versus Alpha Metallurgical Resources Inc (AMR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Alpha Metallurgical Resources Inc (AMR) is a coking coal company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported AMR revenue for 2026-06-30 was $1.02B. Net income was -$23.3M. Revenue was up 93.9% from 2026-03-31 to 2026-06-30. AMR currently screens at market cap $1.53B and trailing P/E 57.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. AMR currently screens at market cap $1.53B and trailing P/E 57.6.
Not investment advice. Open the ALNY and AMR stock pages for the full models.
Not investment advice.